CCL14 Antikörper
Kurzübersicht für CCL14 Antikörper (ABIN199274)
Target
Alle CCL14 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Spezifität
- Recognized 8 human hepatocellular carcinoma cell lines and 12 human liver cancer surgical specimens tested. There were no detectable positive reactions with other human tumor cell lines and solid tumor specimens. Showed negative reaction to all normal human adult tissues and fetal tissues tested.
-
Aufreinigung
- Protein G purified
-
Immunogen
-
Human liver carcinoma cells.
Type of Immunogen: Cells -
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
-
Approved: ELISA, IF
Usage: Suitable for use in ELISA and Indirect Immunofluorescence. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- 0.01 M PBS, pH 7.0, 40 % glycerol.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
-
Short term: 4°C
Long term: Add glycerol (40-50%) -20°C.
-
-
- CCL14 (Chemokine (C-C Motif) Ligand 14 (CCL14))
-
Andere Bezeichnung
- Hcc1 / CCL14
-
Hintergrund
-
Name/Gene ID: CCL14
Subfamily: Intercrine beta
Family: Intercrine
Synonyms: CCL14, CC-3, C-C motif chemokine 14, Chemokine cc3, Chemokine CC-1/CC-3, Chemokine cc1, Chemokine CC-3, HCC-1(1-74), Hcc3, HCC-1, HCC-3, MCIF, NCC-2, SCYA14, Small-inducible cytokine A14, SY14, CC-1, CKB1, HCC1, Hemofiltrate CC chemokine 1, NCC2, New CC chemokine 2 -
Gen-ID
- 6358
-
UniProt
- Q16627
Target
-